Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole
- PMID: 307940
- PMCID: PMC352372
- DOI: 10.1128/AAC.13.6.969
Susceptibility of Haemophilus influenzae type b to rifampin and sulfisoxazole
Abstract
A total of 100 and 97% of Haemophilus influenzae type b strains from major infections were susceptible, respectively, to levels of rifampin and sulfisoxazole attainable in saliva. It is theoretically feasible to eliminate Haemophilus influenzae from the nasopharynx with these drugs.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
